Sekadde-Kigondu C, Mwathe E G, Ruminjo J K, Nichols D, Katz K, Jessencky K, Liku J
Department of Clinical Chemistry, University of Nairobi.
East Afr Med J. 1996 Dec;73(12):786-94.
This paper reports on a prospective study conducted between June 1990 and June 1992 to determine method acceptability, user satisfaction and continuation rates for three highly effective and reversible contraceptive methods currently available in Kenya: the CuT 380A (IUCD), the injectable, Depo-Provera and the low-dose oral contraceptive pill, Microgynon. A non-randomised sample of volunteer participants was used. One thousand and seventy-six users were followed up for a period of one year or up to the time of discontinuation of the method, whichever came earlier. Analysis revealed method specific differences in users' characteristics. The OC users were younger and had fewer children than the IUCD or Depo-Provera users. The Depo-Provera users were older, and had the largest family sizes. Many OC users (almost 40%) were single, while almost three-quarters of IUCD and Depo-Provera users were married. IUCD users were also more educated compared to OC and Depo-Provera users. Survival analysis was used to calculate cumulative life table discontinuation rates by method for the 12 month period. Discontinuation rates were highest for OC users (80%) and lowest for IUCD users (20%) and intermediate for Depo-Provera users (39%). Ninety percent of OC and Depo-Provera users and 86% of IUCD users said they were satisfied with their respective methods. While OCs are among the most popular family planning methods in Kenya, they are also one of the most problematic, while IUCD has the fewest compliance problems. Service providers need to address the issue of high discontinuation rates among the young OC users.
本文报道了一项于1990年6月至1992年6月期间进行的前瞻性研究,旨在确定肯尼亚目前可用的三种高效可逆避孕方法的方法可接受性、用户满意度和持续使用率:CuT 380A(宫内节育器)、注射用醋酸甲羟孕酮(Depo-Provera)和低剂量口服避孕药炔雌醇片(Microgynon)。使用了非随机的志愿者样本。对1076名使用者进行了为期一年的随访,或直至该方法停用之时,以较早者为准。分析揭示了不同方法在使用者特征方面的差异。口服避孕药使用者比宫内节育器或醋酸甲羟孕酮使用者更年轻,孩子更少。醋酸甲羟孕酮使用者年龄更大,家庭规模最大。许多口服避孕药使用者(近40%)单身,而宫内节育器和醋酸甲羟孕酮使用者中近四分之三已婚。与口服避孕药和醋酸甲羟孕酮使用者相比,宫内节育器使用者受教育程度也更高。采用生存分析计算了12个月期间按方法划分的累积生命表停用率。口服避孕药使用者的停用率最高(80%),宫内节育器使用者最低(20%),醋酸甲羟孕酮使用者居中(39%)。90%的口服避孕药和醋酸甲羟孕酮使用者以及86%的宫内节育器使用者表示对各自的方法满意。虽然口服避孕药是肯尼亚最受欢迎的计划生育方法之一,但也是问题最多的方法之一,而宫内节育器的依从性问题最少。服务提供者需要解决年轻口服避孕药使用者中高停用率的问题。